ARTICLE | Clinical News
NanoViricides preclinical data
October 1, 2012 7:00 AM UTC
In mice lethally infected with H3N2 virus, oral FluCide led to a survival time of 15.6 days vs. 9.6 days for Tamiflu oseltamivir and 5 days for untreated controls. FluCide is a nanoviricide designed ...